OCS · CIK 0001953530
OCULIS HOLDING AG
Annual figures as reported, FY2019–FY2025. Ratios and growth rates derived on-page.
Pharmaceutical Preparations
Company profile
Net income
−CHF 99.0M
▼ −15.4% vs FY2024
Free cash flow
−CHF 66.6M
▼ −35.5% vs FY2024
Diluted EPS
−CHF 1.89
▲ +10.8% vs FY2024
Net income
Losses shown in terracotta
Profitability & returns
quality of earningsReturns on capital
Net income vs year-end equity and assets
Return on equityReturn on assets
Cash flow
cash generationFree cash flow
Operating cash flow less capital expenditure
Operating cash flow
Net cash from operations
Shareholder returns
capital allocationDiluted shares outstanding
Falling count means buybacks outpace dilution
Balance sheet
financial positionStockholders’ equity
At fiscal year end
Growth rates
compounding, annualizedShare count change (split-adjusted)
+1925.4%
5y
Key ratios
derived per fiscal year| Fiscal year | ROE | ROA | Current ratio |
|---|---|---|---|
| FY2025 | −50.5% | −41.9% | 5.96× |
| FY2024 | −116.9% | −71.3% | 2.37× |
| FY2023 | −94.7% | −77.7% | 5.29× |
| FY2022 | — | −104.4% | 1.97× |
| FY2021 | — | −32.0% | 11.81× |
| FY2020 | — | — | — |
| FY2019 | — | — | — |
Annual figures
as reported| Fiscal year | Revenue | Gross profit | Op. income | Net income | Diluted EPS | Op. cash flow | Capex | Total assets | Liabilities | Equity | Cash | LT debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 | — | — | −CHF 81.7M | −CHF 99.0M | −CHF 1.89 | −CHF 66.3M | CHF 301K | CHF 236.0M | CHF 39.9M | CHF 196.1M | CHF 81.3M | — |
| FY2024 | — | — | −CHF 73.2M | −CHF 85.8M | −CHF 2.12 | −CHF 48.9M | CHF 230K | CHF 120.4M | CHF 47.0M | CHF 73.4M | CHF 27.7M | — |
| FY2023 | — | — | −CHF 80.7M | −CHF 88.8M | −CHF 2.97 | −CHF 55.0M | CHF 48K | CHF 114.4M | CHF 20.6M | CHF 93.7M | CHF 38.3M | — |
| FY2022 | — | — | −CHF 32.4M | −CHF 38.7M | −CHF 11.32 | −CHF 25.1M | CHF 65K | CHF 37.1M | CHF 135.1M | −CHF 98.0M | CHF 19.8M | — |
| FY2021 | — | — | −CHF 13.2M | −CHF 18.6M | −CHF 5.84 | −CHF 13.8M | CHF 28K | CHF 58.0M | CHF 119.0M | −CHF 61.0M | CHF 46.3M | — |
| FY2020 | — | — | −CHF 12.3M | −CHF 14.9M | −CHF 5.77 | −CHF 12.0M | CHF 19K | — | — | −CHF 43.7M | CHF 5.0M | — |
| FY2019 | — | — | — | — | — | — | — | — | — | −CHF 29.2M | CHF 12.2M | — |
Latest filings
the most recent regulatory filings6-KForeign issuer report2026-06-25 ↗6-KForeign issuer report2026-06-01 ↗6-KForeign issuer report2026-05-14 ↗6-KForeign issuer report2026-05-11 ↗SCHEDULE 13G/ASEC filing2026-04-29 ↗6-KForeign issuer report2026-04-21 ↗SCHEDULE 13G/ASEC filing2026-03-27 ↗144Notice of proposed insider sale2026-03-09 ↗6-KForeign issuer report2026-03-04 ↗F-3ASRSEC filing2026-03-04 ↗
Company logos by Elbstream and unavatar.
All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.